Interventions to Improve Specialty Medication Adherence

Status Completed

Clinical Trial Summary

Patients deemed nonadherent to their specialty medications will be randomized to receive 8 months of patient-tailored adherence interventions and follow up from a specialty pharmacist as needed or the standard of care. Medication adherence will be measured using proportion of days covered (PDC) at 8-months post-randomization to determine if the intervention improved specialty medication adherence.

Clinical Trial Description

This will be a single-center, prospective, randomized controlled trial. A report of patients who use the Vanderbilt Specialty Pharmacy (VSP) will be generated daily for patients with a proportion of days covered (PDC) < 90% in the previous 4 and 12 months based on pharmacy claims. Patients who meet criteria will be randomized to receive an intervention corresponding to their specific reason for nonadherence and follow up from a specialty pharmacist or to receive usual care. For patients who are randomized to receive an intervention, the specialty pharmacist will review their medication fill history and electronic health record to identify potential reasons for nonadherence or to see if the pharmacy claims inappropriately categorized them as nonadherent (this could be due to holding treatment for a clinical reason, transferring the prescription outside of VSP or other reasons listed in Table 2). After reviewing the patient's pharmacy and medical history, if the pharmacist believes they are truly nonadherent (not taking medication as prescribed), the patient will be contacted to identify potential reasons for nonadherence and intervention(s) will be provided to combat the identified reasons for nonadherence. Adherence rates for those receiving the additional adherence interventions and those receiving standard of care will be calculated 8 months after the date of randomization. The reasons for nonadherence and the intervention to improve adherence rates will be documented in a secured REDCap database. It is important to note that the adherence pharmacist is not study staff, but a full-time employee of the health-system specialty pharmacy performing normal specialty pharmacist functions. The randomization to receive these services or not will allow for evaluation of their efficacy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03709277
Study type	Interventional
Source	Vanderbilt University Medical Center
Contact
Status	Completed
Phase	N/A
Start date	May 10, 2019
Completion date	April 10, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05546931` - Mobile Health Program for Rural Hypertension	N/A
Recruiting	`NCT04316715` - Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care	N/A
Active, not recruiting	`NCT04602468` - Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER)	Phase 4
Active, not recruiting	`NCT04588883` - Strengthening Families Living With HIV in Kenya	N/A
Enrolling by invitation	`NCT04676204` - Relationship Between Oral DMT Burden and Adherence in MS
Not yet recruiting	`NCT03807388` - ReMindCare App for Patients From First Episode of Psychosis Unit.	N/A
Completed	`NCT05168449` - The Impact of Pharmacist-led Mobile Application on Adherence in Chronic Kidney Disease Patients	N/A
Active, not recruiting	`NCT04612088` - Intervention for Multivitamin Adherence on Bariatric Patients	N/A
Completed	`NCT03958331` - Behavioral Economics and Adherence in Teens (BEAT!)	N/A
Completed	`NCT05233644` - Medication Adherence in Heart Failure After Hospitalisation
Completed	`NCT03837496` - Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors	N/A
Recruiting	`NCT03683966` - MigALastat Therapy Adherence Among FABRY Patients: A Prospective Multicentral Observational Study
Withdrawn	`NCT04754867` - Pre-Test of For the Future Self and Smoking Cessation	N/A
Recruiting	`NCT05996094` - Antiretroviral Adherence and Drug-level Monitoring
Not yet recruiting	`NCT06056037` - Making ART Work Among Brazilian Youth	N/A
Completed	`NCT03651596` - Leveraging mHealth Messaging to Promote Adherence in Teens With CKD	N/A
Completed	`NCT03842436` - Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use	Phase 4
Completed	`NCT03658252` - Efficacy of Targeted Intervention for Topical Steroid Phobia.	N/A
Completed	`NCT03081559` - Improving Engagement in HIV Care for High-risk Women	N/A
Recruiting	`NCT05515497` - BMT4me: Post-HSCT Medication Adherence mHealth App	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.